PlushCare review
PlushCare (a Transcarent, Inc. subsidiary) is a virtual primary-care platform whose board-certified MDs can prescribe brand-name GLP-1s (via insurance or Novo Nordisk's NovoCare cash-pay program) or compounded semaglutide/tirzepatide in a roughly 39-state footprint.
- Semaglutide
- $199/mo (0.25 mg dose, plus a separate fee, brand-name)
- Tirzepatide
- $399/mo (5 mg dose, plus a separate fee, compounded)
- Coverage
- All 50 states
- Brand-name
- Yes
Semaglutide · modeled / year
$2,388
Tirzepatide · modeled / year
$4,788
Pricing verified August 2026
The Index scorecard
PlushCare scored on our six Cost-Efficiency Index factors. See the methodology.
Where the value is
- Board-certified physicians (not NP-only) available in all 50 states for general virtual primary care
- Publishes an unusually granular compounded-tirzepatide dose ladder ($399/$599/$749 by vial count) instead of a vague single 'starting at' figure
- Brand Wegovy via NovoCare's manufacturer program can beat most compounded prices ($199-399/mo) when the promotion is genuinely still active
- Owned by Transcarent, a venture-backed platform with a named, traceable corporate lineage
- Insurer prior-authorization outreach and an in-app prescription discount card for patients who do have coverage
The tradeoffs
- Compounded tirzepatide and semaglutide are each only available in about 39 states plus DC, narrower than PlushCare's general 50-state telehealth business
- A $19.99/mo membership and, for uninsured patients, a $129 visit fee sit on top of every medication price and are easy to miss from the headline drug price alone
- The advertised NovoCare Wegovy pricing is explicitly time-boxed by the manufacturer ('valid through March 2026' on the live page) — that date has already passed, so the checkout rate may differ from what's displayed
- Facing a class-action settlement (Robbins v. PlushCare) alleging patients were enrolled in a recurring monthly subscription without clear disclosure or an easy cancellation path
- GLP-1 prescribing is a clinician's in-visit judgment call, not guaranteed at signup
The bottom line
Best for: Patients who want a real board-certified physician managing GLP-1s alongside general primary care, and are prepared to navigate insurance or a manufacturer cash-pay program rather than a single flat price. PlushCare (a Transcarent, Inc. subsidiary) is a virtual primary-care platform whose board-certified MDs can prescribe brand-name GLP-1s (via insurance or Novo Nordisk's NovoCare cash-pay program) or compounded semaglutide/tirzepatide in a roughly 39-state footprint.
Ranked #166 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.
Compare with other providers
All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to PlushCare.
- #168RestorLife Med— RestorLife Med is a physician-guided GLP-1 telehealth practice.65/100
- #169SnagRx— SnagRx is a telehealth platform offering compounded semaglutide and tirzepatide with unusually specific named pharmacy partners (RedRock, Health Warehouse, Precision Compounding, Triad Rx) and a claimed LegitScript certification.65/100
- #170Teleios Health— Teleios Health markets itself as a physician-led GLP-1 telehealth provider offering both compounded semaglutide and tirzepatide.65/100
- #171YourEra— Two molecules, two headline prices, and two different reasons neither headline is what you will actually be billed in month two.62/100
- #172Levity— Levity is a telehealth weight-loss provider dispensing only FDA-approved branded GLP-1 medications Ozempic ($1,199/mo), Mounjaro ($1,299/mo) and Wegovy ($1,599/mo), all all-inclusive of consultation, prescription and shipping.64/100
- #173AlyveRx— AlyveRx (Alyve) is a telehealth platform selling compounded semaglutide and tirzepatide in both standard injection and proprietary PermeAct sublingual-drop form, plus brand Ozempic, Wegovy.64/100
The 18 programs nearest this one
Pricing, states and verification reflect PlushCare's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on PlushCare's site. Not medical advice; see our disclosure.